Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Owned and operated by JobMatchingPartner Limited since 2019. Registered office: Centris Business Gateway II, Level 2G, Triq is-Salib Ta L-Imriehel, Zone 3 Central Business District Birkirkara CBD 3020 MALTA Recruitment Licence EA issued by the D.I.E.R.